Genetic Association of the KLK4 Locus with Risk of Prostate Cancer
The Kallikrein-related peptidase, KLK4, has been shown to be significantly overexpressed in prostate tumours in numerous studies and is suggested to be a potential biomarker for prostate cancer. KLK4 may also play a role in prostate cancer progression through its involvement in epithelial-mesenchyma...
Main Authors: | Lose, Felicity, Srinivasan, Srilakshmi, O’Mara, Tracy, Marquart, Louise, Chambers, Suzanne, Gardiner, Robert A., Aitken, Joanne F., Spurdle, Amanda B., Batra, Jyotsna, Clements, Judith A. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435290/ |
Similar Items
-
Association between Prostinogen (KLK15) Genetic Variants and Prostate Cancer Risk and Aggressiveness in Australia and a Meta-Analysis of GWAS Data
by: Batra, Jyotsna, et al.
Published: (2011) -
A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival
by: Batra, Jyotsna, et al.
Published: (2011) -
KLK-targeted Therapies for Prostate Cancer
by: Hannu, Koistinen, et al.
Published: (2014) -
Meta-analysis of gene expression studies in endometrial cancer identifies gene expression profiles associated with aggressive disease and patient outcome
by: O’Mara, Tracy A., et al.
Published: (2016) -
Physiological variables and molecular study of KLK2 and KLK3 among patient with benign prostatic hyperplasia
by: Mustafa F. Dawood, et al.
Published: (2018-09-01)